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Production of Shigella dysenteriae Type 1-Like Cytotoxin by Escherichia coli 
Alison D. O'Brien, Gerald D. LaVeck, 
Michael R. Thompson,* and Samuel B. Formal 
From the Department of Microbiology, Uniformed Services 
University ofthe Health Sciences, Bethesda, Maryland; and 
the Walter Reed Army Institute of Research, 
Washington, D.C. 
Strains of Escherichia coli previously implicated or proven to be causes of diarrhea were 
examined for production of a toxin similar to that of Shigella dysenteriae type 1 (Shiga). 
Organisms grown in an iron-depleted broth were lysed by pressure disruption followed 
by ultracentrifugation. Saline-dialyzed extracts were tested for cytotoxic effects on 
HeLa cells that were neutralizable with antiserum toShiga toxin. Among the 13 E. coli 
strains o analyzed, 11 made a Shiga-like cytotoxin i  levels ranging from trace (two 
avirulent isolates) to amounts equivalent o S. dysenteriae type 1 (two noninvasive 
strains that did not make E. coli heat-labile or -stable nterotoxins but were isolated 
from infants with diarrhea). As with extracts of Shiga toxin, lysates of these E. coli 
strains that produced high levels of Shiga-like toxin were enterotoxic for rabbits, 
paralytic and lethal for mice, and inhibited protein synthesis in HeLa cells. Thus, these 
data suggest that Shiga-like toxin may be another heretofore undiscovered factor in the 
pathogenesis of diarrhea caused by some E. coli strains. 
Two mechanisms have been described by which 
Escherichia coli can cause diarrheal disease in hu- 
mans and animals [1]. Some strains colonize the 
small bowel and cause fluid secretion by elabora- 
tion of heat-labile (LT) and/or heat-stable (ST) 
enterotoxins [2-4]. In contrast to these nonin- 
vasive, enterotoxic organisms, certain strains of 
E. coli penetrate and multiply within colonic 
epithelial cells [1, 5] and are able to produce 
keratoconjunctivitis in guinea pigs (the S6reny 
test) [6]. Infection with these enteroinvasive 
strains may cause symptoms that mimic those seen 
in patients with shigellosis [1, 5, 7]. That E. coli 
must be capable of mediating gastroenteritis by 
other means is indicated by the finding that some 
strains associated with diarrheal disease produce 
no detectable LT or ST and are S6reny test-nega- 
tive [8-10]. Instead, such organisms have been 
shown by electron microscopic studies to displace 
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the microvilli and adhere to the cell membrane of 
intestinal epithelial cells. Invasion of the epithelial 
cells occurs but apparently with less frequency and 
perhaps by a mechanism different from that of 
shigellae [10-12]. 
In a preliminary report [13] we indicated that 
some of these LT-negative, ST-negative, S6reny 
test-negative organisms can produce a toxin like 
that of Shigella dysenteriae type 1 (Shiga)- that is, 
the cytotoxicity is neutralizable by antiserum to 
Shiga toxin-and suggested that this toxin could 
be responsible for the diarrhea-evoking potential 
of these microbes. Subsequently, we had difficulty 
in consistently reproducing these findings. How- 
ever, we recently observed [14] that the yield of 
Shiga toxin can be increased if the organisms are 
grown in alkaline medium or medium pretreated 
with the iron-chelating resin ChelexR (Bio-Rad, 
Richmond, Calif.). The purpose of the present in- 
vestigation was to use these improved culture 
methods to verify that some E. coli isolates do in- 
deed produce Shiga-like toxins. A second interde- 
pendent aim of the study was to determine the re- 
lationship between the pathogenic character (for 
example, enteroinvasive or enterotoxic) of a strain 
of E. coli and its capacity to elaborate Shiga-like 
toxin. 
Materials and Methods 
Bacterial strains. The various bacteria exam- 
ined for production of Shiga-like toxin are 
described in table 1. 
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Table 1. Characteristics of bacterial strains examined in a study of production of Shigella dysenteriae type 1-like 
cytotoxin. 
Culture supernatant 
Diarrhea Rabbit 
Organism, in human ileal Heat-labile Heat-stable Water Sdreny 
strain (serotype) Source volunteers loop test enterotoxin e terotoxin adsorption* testt Reference 
Escherichia coli Laboratory strain, NT Negative Negative Negative NT Negative 15 
K12 strain 1133 avirulent 
(nontypable) 
HS (nontypable) Healthy adult Negative Negative Negative Negative NT Negative 1, 9 
E851/71 (0142: Epidemic infant Positive Negative Negative Negative Positive Negative 9, 16, 17 
K86:H6)t diarrhea 
E74/68 (0128: Epidemic infant Negative Negative Negative Negative Positive Negative 9, 16, 17 
K67:H2)t diarrhea 
12801/0 (0114)t Sporadic infant Positive Negative Negative Negative NT Negative S 
diarrhea 
NC (O125:H21)t Infant diarrhea NT Negative Negative Negative NT Negative 10 
H30 (026)t Infant diarrhea NT Negative Negative Negative NT Negative 18 
S-22-1 (0103: Infant diarrhea NT NT Negative Negative NT Negative 19 
H2:K?) 
RDEC-1 (015) Rabbit diarrhea NT Negative Negative Negative NT Negative 8 
H10407 Adult diarrhea NT Positive Positive Positive Positive Negative 17, 20 
(078:H11 :K2) 
E2531 (O25:K98) Adult diarrhea NT NT Positive Negative NT Negative 21 
TD 514C, Adult diarrhea NT NT Negative Positive NT Negative 22 
(unknown) 
4608-58-899 Adult diarrhea Positive Negative Negative Negative NT Positive 1 
(0143) 
S. dysenteriae Rough avirulent NT Positive Negative Negative Negative Negative 14, 23, 24 
type 1, 60R laboratory strain 
Shigella flexneri Adult dysentery, Positive Negative NT NT NT Positive 1, 25 
type 2a, M4243 passaged in 
monkeys 
Salmonella typhi- Mouse typhoid, NT Negative NT NT NT Negative 26, 27 
murium, W118 virulent in 
monkeys 
Pseudomonas Burn patient NT NT NT NT NT NT None 
aeruginosa 
NOTE. NT = not tested. 
* Inhibition of water adsorption in rat jejuna. 
t Enteroinvasive (causes keratoconjunctivitis in guinea pigs) in Sereny test [6]. 
t Enteropathogenic E. coli of classical serotype (026, 055, 086, 0111, 0114, 0125, 0126, 0127, 0128, or 0142). 
S R. E. Black and M. M. Levine, personal communication. 
Culture medium. Iron-depleted syncase broth, 
briefly described in a previous report [14], was 
prepared as follows. Ten grams of certified cas- 
amino acids (Difco Laboratories, Detroit), 1.17 g 
of NH4C1, 5 g of KH2PO4, 5 g of Na2HPO4, and 1 
ml of trace salts (5% MgSO4 and 0.5% MnC12 in 
0.001 N H2SO4) were dissolved in 1 liter of quartz- 
distilled water, and the pH was adjusted to 8.0 
with 2 N NaOH. Next, 20 g of Chelex 100 (100-200 
mesh; sodium form; Bio-Rad) was added per liter 
of solution, the broth-resin mixture was incubated 
for 2 hr at 4 C with stirring, and the iron-chelating 
beads were removed by filtration through a large 
Biichner funnel ined with two sheets of filter 
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paper (Whatman o. 1; Arthur H. Thomas, Phila- 
delphia). The medium was then distributed into 
flasks precleaned with cleaning solution (RBS-35; 
Pierce Chemical Co., Rockford, Ill.), a surface- 
active agent that removes iron and other contami- 
nants from glassware. The broth was sterilized for 
20 min at 121 C in an autoclave and then allowed 
to cool, and a sterile solution of 0.2% glucose, 
0.004% L-tryptophan, a d 0.002% nicotinic acid 
that had been treated with 2% Chelex was added. 
To conserve Chelex, the resin was regenerated 
by the following method. The used beads were 
scraped from the Whatman filter paper, boiled in 
10 volumes of 1 N HC1, and washed five times in 
distilled water. The acid-treated Chelex was then 
boiled in 10 volumes of 1 N NaOH and washed 
five times in distilled water, and the excess water 
was removed by suction through a fritted glass 
funnel. 
Preparation of bacterial extracts. Organisms 
were incubated for 48 hr with shaking (260 rpm) at 
37 C. The sample size was 3 liters, distributed as 2 
liters and 1 liter in 4-liter and 2-liter flasks, respec- 
tively. The bacteria were harvested by centrifuga- 
tion at 10,000 g at 4 C for 20 min and washed 
twice in 0.85% NaCl before the wet weight was 
determined. Weights ranged from 2 to 4.0 g/liter 
of medium, and larger bacterial yields generally 
indicated incomplete iron depletion of the broth 
and, consequently, reduced toxin production. The 
organisms were then resuspended in 20 ml of buf- 
fer (0.05 M KC1, 0.01 M MgCl2, and 0.02 M Tris at 
pH 7.4) and disrupted by two passages through a 
French pressure cell at 15,000 psi. Lysates were 
then subjected to ultracentrifugation at 100,000 g 
for 70 min and supernatants were dialyzed against 
0.85% NaCl at 4 C. The protein content of these 
extracts was estimated spectrophotometrically 
[28]. 
Biologic and immunologic assays. Cytotoxici- 
ty tests were performed with HeLa cells (Walter 
Reed Army Institute of Research, Washington, 
D.C.) by the method of Gentry and Dalrymple 
[29]. Neutralization tests were done by mixing 
equal volumes of serially diluted rabbit antiserum 
to Shiga toxin or preimmunization rabbit serum 
with 10 50% cytotoxic doses of toxin contained in 
filtered bacterial extracts and then incubating the 
mixtures for 1 hr at 37 C, followed by overnight 
incubation at 4 C. Rabbit antiserum to Shiga toxin 
was elicited against purified Shiga toxin [23] by a 
previously described immunization protocol [23]. 
A 0. 1-ml aliquot of each toxin-serum ixture was 
then added to HeLa cells. All dilutions were pre- 
pared in Eagle's minimal essential medium with 
Earle's balanced salts (HEM Research, Rockville, 
Md.) plus 2 mM L-glutamine, 10% fetal bovine 
serum (Flow Laboratories, McLean, Va.), 100 
units of penicillin G/ml, and 100 ,Ag of gen- 
tamicin/ml. 
Other analyses performed on some bacterial ex- 
tracts included tests for enterotoxic a tivity by the 
rabbit ileal loop assay [30] and assessments of the 
paralytic and lethal activity for mice [25]. In addi- 
tion, the technique of Brown et al. was used to 
quantitate the effects of certain cytotoxic extracts 
on protein synthesis in HeLa cells [31]. Finally, 
the antigenic relationships among some of the tox- 
ins contained in extracts were assessed by im- 
munodiffusion against rabbit antiserum to Shiga 
toxin. Immunodiffusion plates were prepared as 
described [23]. 
Results 
Bacterial cell extracts and culture supernatants 
from 13 strains of E. coli that had been grown in 
iron-depleted medium were tested for cytotoxic ef- 
fects on HeLa cells that were neutralizable with 
antiserum to Shiga toxin. These particular isolates 
were selected because they were well-characterized 
and represented a pathogenic spectrum that ranged 
from avirulent to virulent by an established iar- 
rhea-evoking mechanism (LT-positive, ST-posi- 
tive, or enteroinvasive) or by undefined means 
(LT-negative, ST-negative, and Sereny test- 
negative). Positive controls for the study included 
lysates and culture supernatants of S. dysenteriae 
type 1 strain 60R, which produces high levels of 
Shiga toxin [14, 23, 24], as well as a strain of 
Shigella flexneri type 2a, which produces Shiga- 
like toxin [25]. Two other bacterial species were 
included in this investigation: Salmonella typhi- 
murium (another Enterobacteriaceae) and the 
unrelated gram-negative microbe, Pseudomonas 
aeruginosa. Some pertinent characteristics of 
these microbes are listed in table 1. 
The results of the cytotoxicity evaluations are 
shown in table 2. The organisms were arbitrarily 
grouped into four categories according to the ef- 
fects of the bacterial extract on HeLa cells. Cate- 
gory 1 contained those isolates that made cell- 
associated cytotoxins that were not neutralized by 
rabbit antiserum to Shiga toxin, such as P. aeru- 
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Table 2. Production of cytotoxins, categorized by similarity to the toxin of Shigella dysenteriae type 1 (Shiga), by 
various bacterial strains. 
Cytotoxicity for HeLa cells Cytotoxicity 
CD50/ml CDso/mg neutralized by rabbit 
of culture of protein in antiserum to Shiga 
Category Toxin production Bacteria supernatant bacterial extract toxin (titer)* 
1 Cytotoxin not Shiga-like Escherichia coli 
E2531 ND 9 No 
NC ND 15 No 
Pseudomonas aeruginosa ND 60 No 
2 Trace levels of Shiga-like E. coli 
toxin (<10 CD50/mg of K12 (strain 1133) ND 2 Yes (1:3,200) 
bacterial extract) HS ND 10 Yes (1:6,400) 
3 Low to moderate levels of Salmonella typhimurium 
Shiga-like toxin W118 ND 20 Yes (1:6,400) 
E. coli 
TD 514C, ND 20 Yes (1:6,400) 
RDEC-1 ND 40 Yes (1:12,800) 
460-8-58-899 ND 40 Yes (1:6,400) 
E74/68 ND 60 Yes (1:6,400) 
E851/71 ND 100 Yes (1:6,400) 
H10407 ND 100 Yes (1:3,200) 
12801/0 ND 200 Yes (1:1,600) 
Shigella flexneri type 
2a (strain M4243) 50 300 Yes (1:3,200) 
4 High levels of Shiga or E. coli 
Shiga-like toxin H30 1 x 103 1 x 104 Yes (1:800) 
S-22-1 1 x 104 4 x 104 Yes (1:3,200) 
S. dysenteriae type 1 1 x 104 3 x 105 Yes (1:1,600-1:6,400) 
(strain 60R) 
NOTE. CDSo = cytotoxic doses required to kill 50% of HeLa cells; ND = not detected. * Highest dilution of serum that completely protected HeLa cells from 10 CD5o Of toxin. 
ginosa. The microbes assigned to category 2 (trace 
levels of Shiga-like cell-associated cytotoxin) in- 
cluded the two avirulent E. coli strains 1133 [15] 
and HS [1, 9]. The agents listed in category 3 (pro- 
ducers of low to moderate levels of Shiga-like 
cytotoxins) included seven strains of E. coli rang- 
ing from an ST-positive strain that produced low 
levels of toxin (TD 514C) [22] to an enteropatho- 
genic strain (12801/0) that made nearly as much 
toxin as S. flexneri type 2a. We found that S. ty- 
phimurium strain W118 [26, 27] also made low 
levels of a cytotoxin, an observation that supports 
the findings of others (F. C. W. Koo and J. Peter- 
son, personal communication). The relationship 
between the S. typhimurium cytotoxin described 
by these investigators and the Shiga-like toxin 
described in the present investigation remains to 
be determined. 
Category 4 included two strains of E. coli that 
made levels of Shiga-like toxin equivalent o the 
strain 60R positive control. One of the microbes, 
strain H30, was described by Konowalchuk et al. 
[18]. They reported that culture filtrates of the 
bacterium were cytotoxic for Vero cells. The other 
organism, strain S-22-1, was obtained from M. 
Gurwith (Michigan State University, East Lansing). 
Gurwith and Williams [19] observed that a culture 
filtrate of the strain, which was isolated from the 
stool of a child with diarrhea, grown in brain- 
heart infusion broth was cytotoxic for HeLa cells. 
That the extracts from these two LT-negative, ST- 
negative, Sereny test-negative strains of E. coli 
isolated from infants with diarrheal disease [18, 
19] do indeed make a toxin similar to Shiga toxin 
was verified by other biologic and immunologic 
tests. Lines of identity were seen when extracts of 
E. coli strain H30, E. coli strain S-22-1, and S. dys- 
enteriae type 1 strain 60R were diffused against 
rabbit antiserum to Shiga toxin (figure 1). Fur- 
thermore, cell extracts of these two strains of 
E. coli, like S. dysenteriae type 1 strain 60R, 
paralyzed and killed mice, inhibited protein syn- 
thesis in HeLa cells, and caused fluid accumula- 
tion in ligated rabbit ileal loops (table 3), as did fil- 
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Figure 1. Results of immunodiffu- 
sion of rabbit antiserum totoxin pro- 
duced by Shigella dysenteriae type 1 
(center well) against crude cell ex- 
tracts of S. dysenteriae type 1 strain 
60R (well A), Escherichia coli strain 
H30 (well B), and E. coli strain 
S-22-1 (well C). 
' ' 
t~,.::." 
tered culture supernatants of the microbes (data 
not shown). By contrast, an extract of E. coli 
strain 12801/0 inhibited protein synthesis in HeLa 
cells but was not lethal for mice or enterotoxic for 
rabbits, and an extract of E. coli K12 strain 1133 
was negative for all three activities. It should be 
noted that the mouse lethality and rabbit entero- 
toxicity assays for purified Shiga toxin are at least 
104 times less sensitive than are tests for cytotoxi- 
city or inhibition of protein synthesis [14, 32]. 
Discussion 
The present study established that some strains of 
E. coli make a Shiga-like toxin and showed that 
among such isolates toxic activity varied as much 
as 10,000-fold. The basis for the diversity in yields 
of cell-associated toxin activity was not examined 
but parallels the situation seen among species of 
shigellae - for example, S. dysenteriae makes 
104-105 more cytotoxic material per milligram of 
cell extract protein than does S. flexneri [14, 25]. 
Several theories may be proposed to explain the 
E. coli strain-dependent differences in elaboration 
of Shiga-like toxin. (1) The regulatory mecha- 
nisms that control toxin production by the 
organisms may be quite distinct. For example, a 
category 4 (high-level producer of toxin) organism 
may make toxin constitutively, whereas toxin 
levels made by E. coli in category 2 or 3 (trace to 
Table 3. Other biologic properties of extracts of representative bacteria in a study of bacterial cytotoxins. 
Lethality for mice Inhibition of protein 
Enterotoxicity for (LDso/,4g synthesis (ID50/mg 
Bacteria rabbits* of protein)t of protein)l 
Shigella dysenteriae type 1, 
strain 60R Yes Yes (50) Yes (105) 
Escherichia coli 
S-22-1 Yes Yes (60) Yes (105) 
H30 Yes Yes (90) Yes (105) 
12801/0 No No Yes (90) 
K12, strain 1133 No No No (<10) 
* Extract tested at a dilution of 1:20. 
t Hind leg paralysis observed before death of mice. S 
IDo50 = dose required to inhibit protein synthesis in HeLa cells by 50%. 
768 O'Brien et al. 
moderate levels of toxin production) may be deter- 
mined by a repressible or inducible mechanism. (2) 
Toxin made by category 2 or 3 microbes may vary 
structurally from that produced by category 4 
bacteria. Perhaps structural differences translate 
to variability in biologic activities. (3) Category 2 
and 3 bacteria may manufacture large amounts of 
biologically inactive toxin that compete with ac- 
tive toxin in bioassays. If the reason for variability 
in toxicity among strains of E. coli is the same as 
that for shigellae, the last postulate is not likely 
because a previous investigation [14] showed that 
no biologically inactive toxin was found in ex- 
tracts of S. flexneri. Genetic and biochemical ex- 
periments should address this issue of variability 
in the quantity of Shiga-like toxin made by isolates 
of E. coli. 
Two lines of circumstantial evidence suggest 
that the Shiga-like toxin may play a role in the 
pathogenesis of some cases of E. coli-conferred 
diarrhea. (1) Two strains of E. coli implicated as 
mediators of gastroenteritis in children made high 
levels of Shiga-like toxin but did not elaborate LT 
or ST and were S6reny test-negative. (2) The 
avirulent E. coli strains 1133 and HS made only 
trace amounts of toxin. This finding suggests that 
if a Shiga-like toxin is in fact a virulence determi- 
nant, then either these isolates do not make 
enough toxin to be detrimental oranother factor 
or factors may be required to confer pathogenici- 
ty. Such a factor could be a mechanism of 
adherence to the intestinal mucosa; indeed, Smith 
and Linggood [33] clearly established that 
enterotoxigenic strains of E. coli that lack the K88 
colonizing factor fail to cause diarrheal disease in 
pigs. That some LT-positive, ST-positive, or 
enteroinvasive strains of E. coli also made low to 
moderate amounts of Shiga-like toxin (table 2) 
does not rule out a role for Shiga-like toxin in 
disease caused by E. coli. Rather, enterotoxic 
strains uch as E. coli strain H10407 may colonize 
a region of the intestine where Shiga-like toxin is 
ineffective. Alternatively, Shiga-like toxin may ac- 
tively contribute to the development of clinical 
manifestations in E. coli strain H14047-induced 
diarrhea. Obviously, further studies are required 
to define the role (if any) of Shiga-like toxin in the 
pathogenesis of diarrhea. These investigations could 
include an examination of whether the toxin func- 
tions in vivo as an enterotoxin or as a cytotoxin. 
The structural relationship between Shiga and 
Shiga-like toxins was not examined in this investi- 
gation. The fact that Shiga-like toxic activity can 
be neutralized by antiserum to purified Shiga tox- 
in suggests some degree of homology between the 
toxins. Other data that support he hypothesis that 
the molecules are physically similar include the 
range of biologic activities of the two moieties and 
the immunodiffusion results. Shiga toxin appears 
to be composed of two subunits: an enzymatically 
active A subunit (-30,500 daltons) that when 
nicked and reduced inactivates 60S ribosomes and 
inhibits peptide chain elongation and six or more 
copies of a B subunit (-5,000 daltons) that is 
presumed to function in the binding of toxin to the 
target cell [34, 35]. Thus, Shiga-like toxins prob- 
ably contain one or both of these components. 
Purification of the toxic material from E. coli 
strain H30 should clarify this issue. 
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